Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma

NCT00022893 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Iodine-131 Anti-B1 Antibody

Sponsor

Corixa Corporation

Collaborators

[object Object]